XML 32 R21.htm IDEA: XBRL DOCUMENT v3.23.2
Basis of Presentation and Significant Accounting Policies (Tables)
6 Months Ended
Jun. 30, 2023
Accounting Policies [Abstract]  
Schedule of Reconciliation of Cash, Cash Equivalents and Restricted Cash

The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the condensed consolidated statements of cash flows that sum to the total of the same such amounts shown in the condensed consolidated statements of cash flows (in thousands):

 

 

 

Six Months Ended June 30, 2023

 

 

Six Months Ended June 30, 2022

 

 

 

Beginning of
period

 

 

End of
period

 

 

Beginning of
period

 

 

End of
period

 

Cash and cash equivalents

 

$

114,846

 

 

$

107,941

 

 

$

147,435

 

 

$

139,833

 

Restricted cash

 

 

5,770

 

 

 

8,120

 

 

 

5,770

 

 

 

5,770

 

Total cash, cash equivalents and restricted cash shown in
   the condensed consolidated statements of cash flows

 

$

120,616

 

 

$

116,061

 

 

$

153,205

 

 

$

145,603

 

 

Schedule of revenue consist of product sales to customers

The Company operates in one business segment. Results of its operations are reported on a consolidated basis for purposes of segment reporting, consistent with internal management reporting. Revenues consist of net product sales to customers, all of which are sales in the U.S. Revenues by product are as follows (in thousands):

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

NUPLAZID

 

$

142,018

 

 

$

134,563

 

 

$

260,480

 

 

$

250,031

 

DAYBUE

 

 

23,217

 

 

 

 

 

 

23,217

 

 

 

 

   Product sales, net

 

$

165,235

 

 

$

134,563

 

 

$

283,697

 

 

$

250,031